List of Nicorette drug patents

Nicorette is owned by Glaxosmithkline.

Nicorette contains Nicotine Polacrilex.

Nicorette has a total of 3 drug patents out of which 0 drug patents have expired.

Nicorette was authorised for market use on 09 February, 1996.

Nicorette is available in gum, chewing;buccal dosage forms.

The generics of Nicorette are possible to be released after 14 June, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8323683 GLAXOSMITHKLINE Flavoring of drug-containing chewing gums
Apr, 2028

(5 years from now)

US8940772 GLAXOSMITHKLINE Nicotine lozenge composition
Apr, 2029

(6 years from now)

US8501164 GLAXOSMITHKLINE Nicotine lozenge compositions
Jun, 2029

(6 years from now)

Drugs and Companies using NICOTINE POLACRILEX ingredient

Market Authorisation Date: 09 February, 1996

Treatment: NA

Dosage: GUM, CHEWING;BUCCAL

How can I launch a generic of NICORETTE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in